NCT03784014 2025-12-11MULTISARCInstitut National de la Santé Et de la Recherche Médicale, FrancePhase 3 Active not recruiting603 enrolled
NCT02386826 2023-09-21INC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeSCRI Development Innovations, LLCPhase 1 Completed65 enrolled
NCT01870726 2018-05-30Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent GlioblastomaNovartisPhase 1/2 Terminated43 enrolled 22 charts